• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR INC. TREK; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR INC. TREK; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS Back to Search Results
Model Number 1012276-25
Device Problems Detachment Of Device Component (1104); Difficult to Remove (1528); Device Dislodged or Dislocated (2923)
Patient Problem Foreign Body In Patient (2687)
Event Date 05/30/2018
Event Type  Injury  
Event Description
The catheter shaft became detached from the balloon, leaving the balloon inflated inside the right coronary artery.Additional intervention required to remove balloon.No further intervention was required for this patient.The balloon was able to be retrieved from the coronary artery after manipulation only: the balloon was able to be manipulated and pulled back into the guide catheter.However, it was not able to be removed from the guide catheter so the guide wire, guide catheter and balloon all needed to be removed from the patient as a complete unit.Calcification/plaque was present: it was a calcified lesion that the md had used an atherectomy device on prior to ballooning and stenting.Ninety (90%) occlusion of the vessel.Manufacturer response for abbott vascular, trek rx 3.50mm x25mm (per site reporter): pending.
 
Event Description
The catheter shaft became detached from the balloon, leaving the balloon inflated inside the right coronary artery.Additional intervention required to remove balloon.No further intervention was required for this patient.The balloon was able to be retrieved from the coronary artery after manipulation only: the balloon was able to be manipulated and pulled back into the guide catheter.However, it was not able to be removed from the guide catheter so the guide wire, guide catheter and balloon all needed to be removed from the patient as a complete unit.Calcification/plaque was present: it was a calcified lesion that the md had used an atherectomy device on prior to ballooning and stenting.90% occlusion of the vessel.Manufacturer response for abbott vascular, trek rx 3.50mm x25mm (per site reporter) : pending.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TREK
Type of Device
CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS
Manufacturer (Section D)
ABBOTT VASCULAR INC.
3200 lakeside drive
santa clara CA 95054 2807
MDR Report Key7632320
MDR Text Key112217532
Report Number7632320
Device Sequence Number1
Product Code LOX
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 06/05/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number1012276-25
Device Catalogue Number1012276-25
Device Lot Number60624G1-3274
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Device Age1 DY
Event Location Hospital
Date Report to Manufacturer06/15/2018
Initial Date Manufacturer Received Not provided
Initial Date FDA Received06/22/2018
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received06/25/2018
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Weight185
-
-